Teva May Raise Forecast After Provigil Decision, Analyst Says

Teva Pharmaceutical may raise its earnings forecast when it reports results next month to reflect the U.S. Food and Drug Administration’s decision on the narcolepsy drug Provigil, an analyst said.
Bloomberg